ES2192840T3 - Laxante osmotico no fermentado para tratar y prevenir cancer colorrectal. - Google Patents

Laxante osmotico no fermentado para tratar y prevenir cancer colorrectal.

Info

Publication number
ES2192840T3
ES2192840T3 ES99916994T ES99916994T ES2192840T3 ES 2192840 T3 ES2192840 T3 ES 2192840T3 ES 99916994 T ES99916994 T ES 99916994T ES 99916994 T ES99916994 T ES 99916994T ES 2192840 T3 ES2192840 T3 ES 2192840T3
Authority
ES
Spain
Prior art keywords
fermented
laxant
osmotic
treat
prevent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES99916994T
Other languages
English (en)
Inventor
Denis E Corpet
Sylviane Tache
Geraldine Parnaud
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Recherche Agronomique INRA
Ecole Nationale Veterinaire de Toulouse ENVT
Original Assignee
Institut National de la Recherche Agronomique INRA
Ecole Nationale Veterinaire de Toulouse ENVT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9813450A external-priority patent/FR2784896B1/fr
Application filed by Institut National de la Recherche Agronomique INRA, Ecole Nationale Veterinaire de Toulouse ENVT filed Critical Institut National de la Recherche Agronomique INRA
Application granted granted Critical
Publication of ES2192840T3 publication Critical patent/ES2192840T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/77—Polymers containing oxygen of oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Utilización de un laxante osmótico no fermentado como agente activo para la preparación de un medicamento destinado al tratamiento y/o a la prevención de los cánceres de colon y/o de recto.
ES99916994T 1998-10-27 1999-05-05 Laxante osmotico no fermentado para tratar y prevenir cancer colorrectal. Expired - Lifetime ES2192840T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9813450A FR2784896B1 (fr) 1998-10-27 1998-10-27 Utilisation du polyethylene-glycol dans le traitement et la prevention des cancers colorectaux
FR9903240A FR2784897B1 (fr) 1998-10-27 1999-03-16 Utilisation d'un laxatif osmotique non fermente dans le traitement et la prevention des cancers colorectaux

Publications (1)

Publication Number Publication Date
ES2192840T3 true ES2192840T3 (es) 2003-10-16

Family

ID=26234618

Family Applications (1)

Application Number Title Priority Date Filing Date
ES99916994T Expired - Lifetime ES2192840T3 (es) 1998-10-27 1999-05-05 Laxante osmotico no fermentado para tratar y prevenir cancer colorrectal.

Country Status (13)

Country Link
US (1) US6939563B2 (es)
EP (1) EP1124566B1 (es)
AT (1) ATE232390T1 (es)
AU (1) AU758348B2 (es)
BR (1) BR9914794A (es)
CA (1) CA2347170C (es)
DE (1) DE69905384T2 (es)
DK (1) DK1124566T3 (es)
ES (1) ES2192840T3 (es)
FR (1) FR2784897B1 (es)
NZ (1) NZ511150A (es)
PT (1) PT1124566E (es)
WO (1) WO2000024407A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE477790T1 (de) * 2001-10-29 2010-09-15 Ajinomoto Kk Lösung zur darmreinigung
WO2006073430A2 (en) * 2004-04-20 2006-07-13 The University Of Chicago Therapeutic delivery system comprising a high molecular weight peg-like compound
GB0409104D0 (en) * 2004-04-23 2004-05-26 Norgine Europe Bv Compressed pharmaceutical compositions
US9198847B2 (en) * 2004-11-05 2015-12-01 The Procter & Gamble Company Personal care composition containing a non-guar galactomannan polymer derivative and an anionic surfactant system
CA2607250C (en) * 2005-05-06 2012-11-06 Salix Pharmaceuticals, Inc. Polyethylene glycol colonic purgative composition
AU2013202513B2 (en) * 2005-05-06 2016-03-24 Salix Pharmaceuticals, Inc. Polyethylene glycol colonic purgative composition
US7495063B2 (en) * 2006-02-03 2009-02-24 Dow Global Technologies Inc. Reduced oligomer concentration in high purity polyalkylene glycols
US20090252702A1 (en) * 2006-04-24 2009-10-08 Bruce Medical Ab Polymer-based anti-cancer agents
GB2447067A (en) * 2007-02-20 2008-09-03 Branko R Babic Alteration of osmotic gradients by polyhydroxy compounds
GB201018650D0 (en) * 2010-11-04 2010-12-22 Norgine Bv Methods and compositions
EP3137167A4 (en) 2014-04-29 2017-12-20 Colonaryconcepts LLC Foods, systems, methods, and kits for providing electrolyte replacement
AU2016226380A1 (en) 2015-03-02 2017-09-21 Colonaryconcepts Llc Compounds and methods for PEG metabolite and PEG breakdown product assays
EP3934663A1 (en) * 2019-03-05 2022-01-12 Dow Global Technologies LLC Polyethyleneglycol derivatives for inducing caspase activity

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR930000861B1 (ko) * 1990-02-27 1993-02-08 한미약품공업 주식회사 오메프라졸 직장투여 조성물

Also Published As

Publication number Publication date
DE69905384D1 (de) 2003-03-20
DE69905384T2 (de) 2003-11-27
FR2784897B1 (fr) 2002-11-29
WO2000024407A1 (fr) 2000-05-04
AU3528399A (en) 2000-05-15
NZ511150A (en) 2003-03-28
FR2784897A1 (fr) 2000-04-28
CA2347170C (fr) 2011-09-20
EP1124566A1 (fr) 2001-08-22
BR9914794A (pt) 2001-07-10
EP1124566B1 (fr) 2003-02-12
CA2347170A1 (fr) 2000-05-04
AU758348B2 (en) 2003-03-20
ATE232390T1 (de) 2003-02-15
US20010051659A1 (en) 2001-12-13
PT1124566E (pt) 2003-06-30
DK1124566T3 (da) 2003-06-02
US6939563B2 (en) 2005-09-06

Similar Documents

Publication Publication Date Title
GB9807639D0 (en) Anti-inflammatory agents
NO20014662L (no) Fremgangsmåter og preparater for behandling av faste tumorer
ES2192840T3 (es) Laxante osmotico no fermentado para tratar y prevenir cancer colorrectal.
DE69826644D1 (de) Topische pharmazeutische zusammensetzung, enthaltend einen cholinergischen wirkstoff oder einen kalziumkanalblocker
PT1161248E (pt) Composição farmacêutica que contém uma fonte de nitrato e um agente acidificante destinada ao tratamento de feridas abertas e queimaduras
EA200200595A1 (ru) Лекарственная форма с высвобождением лекарства под действием гидрогеля
GB0013674D0 (en) Therapeutic use
IL195723A (en) Use of p53 inhibitors for the preparation of medicament
ATE370730T1 (de) Pharmazeutische zubereitungen, die chelatbildner/sequestriermittel enthalten und deren dermatologische verwendung
UA41989C2 (uk) Фармацевтична композиція у вигляді гелю для лікування захворювань шкіри та спосіб лікування інфікованої шкіри
ATE319447T1 (de) Pharmazeutische zubereitungen die clavulansäure oder derivate enthalten zur behandlund von neurologischen störungen
MXPA02012666A (es) Formulaciones farmaceuticas topicas y metodos de tratamiento.
PT1079806E (pt) Preparacoes para a aplicacao de anti-inflamatorios, especialmente, agentes anti-septicos e/ou agentes de promocao da cura de feridas, no tracto respiratorio superior e/ou no ouvido
MY164077A (en) Compositions and uses of et743 for treating cancer
IL125776A (en) Use of a cimicifuga racemosa extract for the manufacture of a drug for treating estrogen-dependent tumors
DK0856312T3 (da) Anvendelse af trospiumchlorid til fremstilling af et lægemiddel til behandling af blæresygdomme
ATE313334T1 (de) Behandlung von tumoren mit photodynamischer therapie
EP1194109A4 (en) TOPICAL FORMULATIONS CONTAINING AGENTS THAT PROMOTE SKIN PENETRATION AND THEIR USE
WO2001041747A3 (de) Pharmazeutische zubeteitung enthaltend zytostatika und electronenakzeptoren zur behandlung von krebs
GEP20043231B (en) Resorcinol Composition
AR027677A1 (es) Una composicion farmaceutica terapeutica que comprende camptotecina y ciclofosfamida para el tratamiento del cancer
RU94024337A (ru) Антиметастатическое средство
SE9700617D0 (sv) New composition
PT874630E (pt) Terapia combinada de um inibidor da topoisomerase ii e um derivado da bis-dioxipiperazina
CA2306772A1 (en) Use of c18 to c26 aliphatic alcohols for the manufacture of a medicament in the treatment of hyperproliferative skin disorders